Literature DB >> 19718279

Quantitative trait locus analysis of neointimal formation in an intercross between C57BL/6 and C3H/HeJ apolipoprotein E-deficient mice.

Zuobiao Yuan1, Hong Pei, Drew J Roberts, Zhimin Zhang, Jessica S Rowlan, Alan H Matsumoto, Weibin Shi.   

Abstract

BACKGROUND: Inbred mouse strains C57BL/6J (B6) and C3H/HeJ (C3H) exhibit marked differences in neointimal formation after arterial injury when deficient in apolipoprotein E (apoE(-/-)) and fed a Western diet. Quantitative trait locus (QTL) analysis was performed on an intercross between B6.apoE(-/-) and C3H.apoE(-/-) mice to determine genetic factors contributing to the phenotype. METHODS AND
RESULTS: Female B6.apoE(-/-) mice were crossed with male C3H.apoE(-/-) mice to generate F(1)s, which were intercrossed to generate 204 male F(2) progeny. At 10 weeks of age, F(2)s underwent endothelium denudation injury to the left common carotid artery. Mice were fed a Western diet for 1 week before and 4 weeks after injury and analyzed for neointimal lesion size, plasma lipid and MCP-1 levels. One significant QTL, named Nih1 (61cM, LOD score: 5.02), on chromosome 12 and a suggestive locus on chromosome 13 (35cM, LOD: 2.67) were identified to influence lesion size. One significant QTL on distal chromosome 1 accounted for major variations in plasma non-HDL cholesterol and triglyceride levels. Four suggestive QTLs on chromosomes 1, 2, and 3 were detected for circulating MCP-1 levels. No correlations were observed between neointimal lesion size and plasma lipid levels or between lesion size and plasma MCP-1 levels.
CONCLUSIONS: Neointimal formation is controlled by genetic factors independent of those affecting plasma lipid levels and circulating MCP-1 levels in the B6 and C3H mouse model.

Entities:  

Keywords:  Mice; Neointimal hyperplasia; Quantitative trait locus; Restenosis

Mesh:

Substances:

Year:  2009        PMID: 19718279      PMCID: PMC2733792          DOI: 10.1161/CIRCGENETICS.108.792499

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  26 in total

1.  A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias.

Authors:  Willem R P Agema; J Wouter Jukema; Aeilko H Zwinderman; E E van der Wall
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

Review 2.  Drug-eluting stents: potential applications for peripheral arterial occlusive disease.

Authors:  Stephan H Duda; Tudor C Poerner; Benjamin Wiesinger; John H Rundback; Gunnar Tepe; Jakub Wiskirchen; Karl K Haase
Journal:  J Vasc Interv Radiol       Date:  2003-03       Impact factor: 3.464

3.  Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data.

Authors:  Susanna S Wang; Eric E Schadt; Hui Wang; Xuping Wang; Leslie Ingram-Drake; Weibin Shi; Thomas A Drake; Aldons J Lusis
Journal:  Circ Res       Date:  2007-07-19       Impact factor: 17.367

4.  Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism.

Authors:  W Shi; N J Wang; D M Shih; V Z Sun; X Wang; A J Lusis
Journal:  Circ Res       Date:  2000-05-26       Impact factor: 17.367

5.  Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting.

Authors:  A Kastrati; W Koch; P B Berger; J Mehilli; K Stephenson; F J Neumann; N von Beckerath; C Böttiger; G W Duff; A Schömig
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.

Authors:  Susanna S Wang; Weibin Shi; Xuping Wang; Leandra Velky; Sarah Greenlee; Min T Wang; Thomas A Drake; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-04       Impact factor: 8.311

Review 7.  Drug-eluting stents in vascular intervention.

Authors:  Rossella Fattori; Tommaso Piva
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

8.  Quantitative trait locus analysis of carotid atherosclerosis in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice.

Authors:  Qiongzhen Li; Yuhua Li; Zhimin Zhang; Timothy R Gilbert; Alan H Matsumoto; Seth E Dobrin; Weibin Shi
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

9.  The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia.

Authors:  Zakar H Mnjoyan; Dennis Doan; Jimi Lynn Brandon; Kumar Felix; Christy L Sitter; Ajay A Rege; Tommy A Brock; Ken Fujise
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-07       Impact factor: 4.733

10.  Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice.

Authors:  David G Kuhel; Binghua Zhu; David P Witte; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  21 in total

1.  Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.

Authors:  Zhimin Zhang; Jessica S Rowlan; Qian Wang; Weibin Shi
Journal:  Circ Cardiovasc Genet       Date:  2012-01-31

2.  Atherogenesis in the Carotid Artery with and without Interrupted Blood Flow of Two Hyperlipidemic Mouse Strains.

Authors:  Jian Zhao; Chaoji Huangfu; Zhihui Chang; Andrew T Grainger; Zhaoyu Liu; Weibin Shi
Journal:  J Vasc Res       Date:  2019-09-19       Impact factor: 1.934

3.  Genetic modifiers of cardiovascular phenotype caused by elastin haploinsufficiency act by extrinsic noncomplementation.

Authors:  Beth A Kozel; Russell H Knutsen; Li Ye; Christopher H Ciliberto; Thomas J Broekelmann; Robert P Mecham
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

4.  Intima modifier locus 2 controls endothelial cell activation and vascular permeability.

Authors:  Elaine M Smolock; Ryan M Burke; Chenjing Wang; Tamlyn Thomas; Sri N Batchu; Xing Qiu; Martha Zettel; Keigi Fujiwara; Bradford C Berk; Vyacheslav A Korshunov
Journal:  Physiol Genomics       Date:  2014-07-01       Impact factor: 3.107

5.  PET imaging detection of macrophages with a formyl peptide receptor antagonist.

Authors:  Yi Zhang; Bijoy Kundu; Min Zhong; Tao Huang; Jing Li; Mahendra D Chordia; Mei-Hua Chen; Dongfeng Pan; Jiang He; Weibin Shi
Journal:  Nucl Med Biol       Date:  2014-12-06       Impact factor: 2.408

6.  Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation.

Authors:  Elaine M Smolock; Vyacheslav A Korshunov; Galina Glazko; Xing Qiu; Janice Gerloff; Bradford C Berk
Journal:  Circulation       Date:  2012-10-12       Impact factor: 29.690

7.  Identification of a genetic locus on chromosome 11 that regulates leukocyte infiltration in mouse carotid artery.

Authors:  Elaine M Smolock; Dietrich E Machleder; Vyacheslav A Korshunov; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-28       Impact factor: 8.311

8.  Genetic modification of corneal neovascularization in Dstn (corn1) mice.

Authors:  Sharolyn V Kawakami-Schulz; Shannon G Sattler; Anna-Lisa Doebley; Akihiro Ikeda; Sakae Ikeda
Journal:  Mamm Genome       Date:  2013-08-09       Impact factor: 2.957

9.  Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.

Authors:  Matthew A Dale; Melissa K Suh; Shijia Zhao; Trevor Meisinger; Linxia Gu; Vicki J Swier; Devendra K Agrawal; Timothy C Greiner; Jeffrey S Carson; B Timothy Baxter; Wanfen Xiong
Journal:  Atherosclerosis       Date:  2015-10-08       Impact factor: 5.162

10.  New quantitative trait loci for carotid atherosclerosis identified in an intercross derived from apolipoprotein E-deficient mouse strains.

Authors:  Jessica S Rowlan; Zhimin Zhang; Qian Wang; Yan Fang; Weibin Shi
Journal:  Physiol Genomics       Date:  2013-03-05       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.